These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8800022

  • 1. Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery.
    Stratmann HG, Younis LT, Wittry MD, Amato M, Mark AL, Miller DD.
    Am Heart J; 1996 Sep; 132(3):536-41. PubMed ID: 8800022
    [Abstract] [Full Text] [Related]

  • 2. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events.
    Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD.
    Am Heart J; 1996 May; 131(5):923-9. PubMed ID: 8615311
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina.
    Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Amato M, Miller DD.
    Am Heart J; 1995 Oct; 130(4):734-40. PubMed ID: 7572580
    [Abstract] [Full Text] [Related]

  • 4. Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.
    Miller DD, Stratmann HG, Shaw L, Tamesis BR, Wittry MD, Younis LT, Chaitman BR.
    J Nucl Cardiol; 1994 Oct; 1(1):72-82. PubMed ID: 9420673
    [Abstract] [Full Text] [Related]

  • 5. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events.
    McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, Waters D, Heller GV.
    Am J Cardiol; 1997 Mar 01; 79(5):600-5. PubMed ID: 9068516
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise.
    Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD.
    Am J Cardiol; 1994 Apr 01; 73(9):647-52. PubMed ID: 8166059
    [Abstract] [Full Text] [Related]

  • 7. The utility and prognostic value of dipyridamole technetium-99m sestamibi myocardial perfusion imaging SPECT in predicting perioperative cardiac events following non-cardiac surgery.
    Asli IN, Shahoseini R, Azizmohammadi Z, Javadi H, Assadi M.
    Perfusion; 2013 Jul 01; 28(4):333-9. PubMed ID: 23482483
    [Abstract] [Full Text] [Related]

  • 8. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain.
    Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD.
    Circulation; 1994 Feb 01; 89(2):615-22. PubMed ID: 8313549
    [Abstract] [Full Text] [Related]

  • 9. Comparative prognostic value of clinical risk indexes, resting two-dimensional echocardiography, and dipyridamole stress thallium-201 myocardial imaging for perioperative cardiac events in major nonvascular surgery patients.
    Takase B, Younis LT, Byers SL, Shaw LJ, Labovitz AJ, Chaitman BR, Miller DD.
    Am Heart J; 1993 Nov 01; 126(5):1099-106. PubMed ID: 8237751
    [Abstract] [Full Text] [Related]

  • 10. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris.
    Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD.
    Am J Cardiol; 1995 Aug 01; 76(4):236-40. PubMed ID: 7618615
    [Abstract] [Full Text] [Related]

  • 11. Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy.
    Travin MI, Duca MD, Kline GM, Herman SD, Demus DD, Heller GV.
    Am Heart J; 1997 Jul 01; 134(1):73-82. PubMed ID: 9266786
    [Abstract] [Full Text] [Related]

  • 12. Cardiac assessment prior to vascular surgery: is dipyridamole-sestamibi necessary?
    de Virgilio C, Pak S, Arnell T, Donayre C, Lewis RJ, Stabile BE, White R.
    Ann Vasc Surg; 1996 Jul 01; 10(4):325-9. PubMed ID: 8879386
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.
    De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR.
    Am J Cardiol; 2002 Oct 15; 90(8):827-32. PubMed ID: 12372568
    [Abstract] [Full Text] [Related]

  • 15. Thallium-201 perfusion imaging with atrial pacing or dipyridamole stress testing for evaluation of cardiac risk prior to nonvascular surgery.
    Stratmann HG, Mark AL, Williams GA.
    Clin Cardiol; 1990 Sep 15; 13(9):611-6. PubMed ID: 2208820
    [Abstract] [Full Text] [Related]

  • 16. Risk stratification with pre-hospital discharge exercise technetium-99m sestamibi myocardial tomography in men after acute myocardial infarction.
    Stratmann HG, Mark AL, Amato M, Wittry MD, Younis LT.
    Am Heart J; 1998 Jul 15; 136(1):87-93. PubMed ID: 9665223
    [Abstract] [Full Text] [Related]

  • 17. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.
    Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C, McClellan JR.
    J Am Coll Cardiol; 1995 Nov 01; 26(5):1202-8. PubMed ID: 7594033
    [Abstract] [Full Text] [Related]

  • 18. Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly.
    Lima RS, De Lorenzo A, Pantoja MR, Siqueira A.
    Int J Cardiol; 2004 Feb 01; 93(2-3):137-43. PubMed ID: 14975539
    [Abstract] [Full Text] [Related]

  • 19. Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease.
    Younis L, Stratmann H, Takase B, Byers S, Chaitman BR, Miller DD.
    Am J Cardiol; 1994 Aug 15; 74(4):311-7. PubMed ID: 8059690
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation.
    Mistry BM, Bastani B, Solomon H, Hoff J, Aridge DL, Lindsey LM, Schmid S, Chaitman BR, Garvin PJ.
    Clin Transplant; 1998 Apr 15; 12(2):130-5. PubMed ID: 9575401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.